Palmoplantar Pustulosis Market to Reach $2.82 Billion by 2029, Growing at a CAGR of 7.7%

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Is The Global Market Value Of The Palmoplantar Pustulosis Industry In 2025?

The palmoplantar pustulosis market has experienced robust expansion in recent years. It is projected to grow from $1.93 billion in 2024 to $2.09 billion in 2025, at a compound annual growth rate (CAGR) of 8.5%. The expansion witnessed in the historic period can be attributed to the increasing prevalence of autoimmune disorders, growing awareness about rare skin diseases, rising healthcare expenditure, and increasing adoption of telemedicine for dermatology.

The palmoplantar pustulosis market is projected to experience robust expansion in the coming years. By 2029, it is anticipated to reach $2.82 billion, demonstrating a compound annual growth rate (CAGR) of 7.7%. This growth throughout the forecast period can be attributed to several factors, including the increasing adoption of biologic therapies, heightened investments in dermatology research, an expanding pipeline of novel treatments, a rising demand for personalized medical approaches, and the growing occurrence of chronic skin conditions. Key trends during this period are expected to encompass significant advancements in dermatology research, a noticeable shift towards biologics and immunomodulators, the incorporation of artificial intelligence into dermatological diagnostics, the creation of sophisticated topical formulations, and the integration of machine learning within dermatological research.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22090&type=smp

Which Industry Drivers Are Expected To Accelerate The Palmoplantar Pustulosis Market From 2025 To 2029?

The rising prevalence of skin conditions is anticipated to drive expansion in the palmoplantar pustulosis market in the future. Skin disorders are defined as ailments impacting the skin’s structure, functionality, or visual aspect. This increase in skin disorder cases stems from environmental shifts, lifestyle choices, and genetic factors. Environmental elements like air pollution, harsh weather, and contact with detrimental chemicals can irritate the skin, resulting in conditions such as eczema or acne. Palmoplantar pustulosis, a chronic dermatological condition, primarily impacts the skin on the palms of the hands and soles of the feet, manifesting as pustules, redness, and scaling; it can be addressed with different therapies to enhance skin health and reduce discomfort. As an illustration, data from the International Eczema Council, a US-based organization, reported in 2022 that approximately 223 million individuals suffered from atopic dermatitis, with around 43 million of these being aged 1 to 4. Consequently, the growing frequency of skin conditions is a key driver for the palmoplantar pustulosis market.

How Is The Palmoplantar Pustulosis Market Classified Into Different Segments?

The palmoplantar pustulosismarket covered in this report is segmented –

1) By Treatment Type: Topical Treatments; Systemic Treatments; Biologics; Phototherapy

2) By Application: Hospitals; Dermatology Clinics; Homecare Settings

3) By Distribution Channel: Online Pharmacies; Retail Pharmacies; Hospitals

Subsegments:

1) By Topical Treatments: Corticosteroids; Vitamin D Analogues; Calcineurin Inhibitors; Keratolytics

2) By Systemic Treatments: Retinoids; Immunosuppressants; Phosphodiesterase-4 (PDE4) Inhibitors; Corticosteroids

3) By Biologics: Tumor Necrosis Factor (TNF) Inhibitors; Interleukin-17 (IL-17) Inhibitors; Interleukin-23 (IL-23) Inhibitors; Interleukin-12/23 (IL-12/23) Inhibitors

4) By Phototherapy: Narrowband UVB Therapy (NB-UVB); Psoralen plus Ultraviolet A (PUVA) Therapy; Excimer Laser Therapy; Targeted Phototherapy

Which Competitive Trends Are Defining The Palmoplantar Pustulosis Market Structure?

Leading companies in the palmoplantar pustulosis market are concentrating on developing innovative treatments, such as monoclonal antibodies that target inflammatory pathways, to achieve better patient outcomes. A monoclonal antibody (mAb) is a uniform antibody generated by a single B cell clone, designed to specifically bind to an antigen for either therapeutic or diagnostic purposes. For example, in August 2023, Kyowa Kirin Co., Ltd., a Japan-based pharmaceutical company, obtained a partial change approval for LUMICEF in Japan for palmoplantar pustulosis. LUMICEF represents a targeted therapy that inhibits IL-17, delivering prompt and enduring relief for inflammatory conditions like psoriasis and palmoplantar pustulosis. Its aim is to decrease inflammation and enhance the quality of life for patients affected by these chronic diseases.

Which Leading Players Are Enhancing Their Palmoplantar Pustulosis Market Presence Worldwide?

Major companies operating in the palmoplantar pustulosis market are Pfizer Inc., AbbVie Inc., Sanofi S.A., Bristol-Myers Squibb Company, Novartis International AG, GlaxoSmithKline PLC (GSK), Amgen Inc., C.H. Boehringer Sohn AG & Co. KG, Bausch Health Companies Inc., Chugai Pharmaceutical Co. Ltd., Janssen Pharmaceuticals Inc., Kyowa Kirin Co. Ltd., Swedish Orphan Biovitrum AB (Sobi), Almirall S.A., MorphoSys AG, MoonLake Immunotherapeutics AG, Aristea Therapeutics Inc., AnaptysBio Inc., Taiho Pharmaceutical Co. Ltd., Kamari Pharma Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/palmoplantar-pustulosis-global-market-report

How Do Regional Market Performances Compare Within The Palmoplantar Pustulosis Industry?

North America was the largest region in the palmoplantar pustulosis market in 2024. The regions covered in the palmoplantar pustulosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Palmoplantar Pustulosis Market Report:

https://www.thebusinessresearchcompany.com/customise?id=22090&type=smp

Browse Through More Reports Similar to the Global Palmoplantar Pustulosis Market 2025, By The Business Research Company

Natural Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/natural-skin-care-products-global-market-report

Organic Skincare Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/organic-skincare-global-market-report

Dna Based Skin Care Products Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dna-based-skin-care-products-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795